Phase 4Completed
A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids (ADVANCE)
Investigating New Onset Diabetes Mellitus in Kidney Transplant Recipients Receiving an Advagraf-Based Immunosuppressive Regimen With or Without Corticosteroids - A Multicenter, Two Arm, Randomized, Open Label Clinical Study
- Sponsor
- Astellas Pharma Inc (Industry)
- Enrollment
- 1,166 enrolled
- Conditions
- Kidney Transplantation
- Interventions
- Advagraf; Mycophenolate Mofetil; Simulect; Corticosteroids
- Ages
- adults, older adults
- Registry
- NCT01304836, EUCTR2010-019638-28
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to focus on potential differences in the occurrence of new-onset Diabetes Mellitus (a glucose metabolism disorder) when two different regimens of immunosuppressive treatment are compared.
Primary outcomes
- Diagnosis of new onset Diabetes Mellitus as per ADA criteria at any point up to 24 weeks after kidney transplantation
History
Last registry update
Primary completion
Registered
Started